Literature DB >> 3009515

Envelope proteins of avian infectious bronchitis virus: purification and biological properties.

A P Mockett.   

Abstract

Immunoadsorbents, made with monoclonal antibodies, were used to purify the spike and membrane proteins of infectious bronchitis virus (IBV). The purified proteins were inoculated into rabbits to produce antisera. The rabbit anti-spike sera neutralized the infectivity of the virus whereas the anti-membrane sera did not. IBV-infected chickens produced antibodies to both the spike and membrane proteins. Both these antibodies were at their highest concentration about 9-11 days after inoculation, whereas neutralizing antibodies were present only at very low concentrations at that time. Neutralizing antibodies were at their highest concentration 21 days after inoculation. A second inoculation of virus at 42 days induced an anamnestic antibody response to the spike and membrane proteins and also for the neutralizing antibodies. The neutralizing, anti-spike and anti-membrane antibodies all reached highest concentrations 7-11 days after this inoculation. The advantages of purifying viral proteins using affinity chromatography with monoclonal antibodies are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3009515      PMCID: PMC7119818          DOI: 10.1016/0166-0934(85)90138-7

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  13 in total

1.  Taxonomic studies on strains of avian infectious bronchitis virus using neutralisation tests in tracheal organ cultures.

Authors:  J H Darbyshire; J G Rowell; J K Cook; R W Peters
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

2.  Presence of viral antigens and antibody in the trachea of chickens infected with avian infectious bronchitis virus.

Authors:  R A Hawkes; J H Darbyshire; R W Peters; A P Mockett; D Cavanagh
Journal:  Avian Pathol       Date:  1983       Impact factor: 3.378

3.  Comparative studies with an enzyme-linked immunosorbent assay (ELISA) for antibodies to avian infectious bronchitis virus.

Authors:  A P Mockett; J H Darbyshire
Journal:  Avian Pathol       Date:  1981-01       Impact factor: 3.378

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Monoclonal antibodies to the S1 spike and membrane proteins of avian infectious bronchitis coronavirus strain Massachusetts M41.

Authors:  A P Mockett; D Cavanagh; T D Brown
Journal:  J Gen Virol       Date:  1984-12       Impact factor: 3.891

6.  The experimental infection of chickens with mixtures of infectious bronchitis virus and Escherichia coli.

Authors:  H W Smith; J K Cook; Z E Parsell
Journal:  J Gen Virol       Date:  1985-04       Impact factor: 3.891

7.  Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus.

Authors:  J O Fleming; S A Stohlman; R C Harmon; M M Lai; J A Frelinger; L P Weiner
Journal:  Virology       Date:  1983-12       Impact factor: 3.616

8.  Assessment of cross-immunity dm chickens to strains of avian infectious bronchitis virus using tracheal organ cultures.

Authors:  J H Darbyshire
Journal:  Avian Pathol       Date:  1980-04       Impact factor: 3.378

9.  Structural polypeptides of coronavirus IBV.

Authors:  D Cavanagh
Journal:  J Gen Virol       Date:  1981-03       Impact factor: 3.891

10.  Sequence of the membrane protein gene from avian coronavirus IBV.

Authors:  M E Boursnell; T D Brown; M M Binns
Journal:  Virus Res       Date:  1984       Impact factor: 3.303

View more
  5 in total

1.  The coronavirus infectious bronchitis virus nucleoprotein localizes to the nucleolus.

Authors:  J A Hiscox; T Wurm; L Wilson; P Britton; D Cavanagh; G Brooks
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Reverse genetics system for the avian coronavirus infectious bronchitis virus.

Authors:  R Casais; V Thiel; S G Siddell; D Cavanagh; P Britton
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  The S1 glycoprotein but not the N or M proteins of avian infectious bronchitis virus induces protection in vaccinated chickens.

Authors:  J Ignjatovic; L Galli
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

4.  Protection from lethal coronavirus infection by affinity-purified spike glycoprotein of murine hepatitis virus, strain A59.

Authors:  C Daniel; P J Talbot
Journal:  Virology       Date:  1990-01       Impact factor: 3.616

Review 5.  Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.

Authors:  Dave Cavanagh
Journal:  Avian Pathol       Date:  2003-12       Impact factor: 3.378

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.